Oral Bioavailability Services
2 services found
-
Manufactured by BriaCell Therapeutics Corp.based in CANADA
Phase I/IIa Combination Study of Bria-IMT™ with retifanlimab (INCMGA00012) and epacadostat in Advanced Breast Cancer. FDA has approved the combination study of Bria-IMT™ with Incyte Corporation’s drugs, retifanlimab and epacadostat. The combination study is listed in ClinicalTrials.gov as NCT03328026. Patients With advanced breast cancer will be eligible for combination therapy ...
-
based in BELGIUM
needs and develop the best possible formulation. We have the capabilities to develop formulations for a very broad range of administration routes, from oral and topical to intranasal, ocular and intravenous. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you